• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Protection against Streptococcus pneumoniae invasive pathogenesis by a protein based vaccine is achieved by suppression of nasopharyngeal bacterial de

tetano

Editor, Senior Moderator
Infect Immun. 2016 Nov 28. pii: IAI.00530-16. [Epub ahead of print]
[h=1]Protection against Streptococcus pneumoniae invasive pathogenesis by a protein based vaccine is achieved by suppression of nasopharyngeal bacterial density during Influenza A virus co-infection.[/h] Khan MN[SUP]1[/SUP], Xu Q[SUP]2[/SUP], Pichichero ME[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] An increase in Streptococcus pneumoniae (Spn) nasopharyngeal (NP) colonization density during a viral co-infection initiates pathogenesis. To mimic natural Spn pathogenesis, we commensally colonized the NP of adult C57BL/6 mice with Spn serotypes (STs) 6A or 8, and then co-infected with mouse-adapted H1N1 influenza A virus (PR/8/34). Spn established effective commensal colonization and Influenza co-infection caused Spn NP density to increase, resulting in bacteremia and mortality. We then studied histidine triad protein D (PhtD), a Spn adhesin vaccine candidate, for its ability to prevent invasive Spn disease in adult and infant mice. In adult mice, the efficacy of PhtD vaccination was compared with that of PCV13. Vaccination with PCV13 led to a greater reduction of Spn NP density (>2.5 log) compared to PhtD vaccination (∼1 log reduction). However, there was no significant difference observed with regard to the prevention of Spn bacteremia and no difference in mortality. Depletion of CD4[SUP]+[/SUP] T cells in PhtD vaccinated adult mice but not PCV13-vaccinated mice caused a loss of vaccine induced protection. In infant mice, passive transfer of antisera or CD4[SUP]+[/SUP] T cells from PhtD vaccinated adult mice led to a non-significant reduction in NP colonization density. Whereas, passive transfer of antisera and CD4[SUP]+[/SUP] T cells was needed to cause a significant reduction in NP colonization density. For the first time these data show a similar outcome with regard to prevention of invasive Spn pathogenesis with a protein vaccine as occurs with a glycoconjugate vaccine despite a less robust reduction in NP bacterial density.
Copyright ? 2016, American Society for Microbiology. All Rights Reserved.


PMID: 27895132 DOI: 10.1128/IAI.00530-16
[PubMed - as supplied by publisher]
 
Back
Top Bottom